NCT06666530

Brief Summary

"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea. After recruitment during a follow-up consultation: Information regarding the prenatal and perinatal management of HIV and the infant's outcomes up to 12 months will be collected retrospectively through the medical records. Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum."

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Jun 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jun 2024May 2028

Study Start

First participant enrolled

June 19, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 30, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

3.5 years

First QC Date

October 21, 2024

Last Update Submit

January 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Collection of perceptions of pregnancy care via the Hospital Anxiety and Depression Scale

    during the Perinatal Period at 1 Year Postpartum

Secondary Outcomes (15)

  • Describe the sociodemographic characteristics of the mothers

    up to 1 year postpartum

  • Describe the course of pregnancy period through different parameters: HIV discovery setting, type of mother's income, administrative status, mother treatments, immunovirological control, intrapartum AZT infusion

    up to 9 month

  • Describe the course of the postpartum period through different parameters: type of mother's income, administrative status, mother and child treatments, immunovirological control, delivery method, characteristics of newborns at birth

    at 1 year postpartum

  • Describe the care of children born to women living with HIV : Collection of clinical and epidemiological data from children

    up to 1 year

  • Describe the serological status of children born to women living with HIV (HIV+ or HIV-)

    at 1 year

  • +10 more secondary outcomes

Study Arms (1)

women living with HIV

women living with HIV during the perinatal period

Other: Questionary

Interventions

Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum

women living with HIV

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women living with HIV followed for a pregnancy in the SMIT of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea

You may qualify if:

  • Woman living with HIV
  • Age ≥ 18 years
  • Pregnant - due date between the first obstetric ultrasound and 28 weeks of amenorrhea
  • Information provided about the study and the right to refuse participation

You may not qualify if:

  • Refusal to participate in the study
  • Non-French speaker"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Bichat-Claude Bernard

Paris, 75018, France

RECRUITING

Study Officials

  • Bachelard Antoine

    Assistance Publique Hopitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2024

First Posted

October 30, 2024

Study Start

June 19, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

May 1, 2028

Last Updated

January 8, 2026

Record last verified: 2026-01

Locations